期刊文献+

OPG/RANK/RANKL系统与骨折和类风湿性关节炎 被引量:10

OPG/RANK/RANKL system in fracture and rheumatoid arthritis
原文传递
导出
摘要 骨保护素(OPG)、细胞核因子-κB受体活化因子(RANK)和RANK配体(RANKL)是偶联成骨细胞、基质细胞和破骨细胞分化、活化及生物活性的3种主要细胞因子,其形成的局部调节体系在骨代谢中起十分重要的作用。本文简要介绍了OPG/RANK/RANKL系统及该系统在骨质疏松性骨折发生中的作用,RANKL/OPG比值与骨折的关系,OPG和RANKL对骨折愈合的作用,血清OPG或RAN-KL水平与骨折的联系,OPG基因多态性与骨折关系的研究结果。另外还介绍其在类风湿性关节炎发病机制中的作用,OPG/RANK/RANKL与滑膜组织的联系,OPG治疗的相关实验进展。 It is an important discovery that the osteoprotegerin(OPG)/receptor activator of nuclear factor kappa B( RANK)/RANK ligand( RANKL)system is in the research of bone metabolism. OPG/KANK/RANKL system plays a vital role in the regulation of bone modeling and remodeling. We here review the OPG/RANK/RANKL system and summarize its functions in osteoporotic fracture, such as the relationship between RANKL/OPG ratio and fracture, the effect of OPG and RANKL to fracture healing etc. We also introduce the relationship between OPG/RANK/RANKL system and rheumatoid arthritis pathogenesis.
出处 《国际内分泌代谢杂志》 2006年第4期241-244,共4页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(30400514) 卫生部临床学科重点建设资助项目(2004-468-50)
关键词 骨保护素 RANK RANKL 骨质疏松 骨折 类风湿性关节炎 OPG RANK RANKL Osteoporosis Fracture Rheumatoid arthritis
  • 相关文献

参考文献29

  • 1Steven RC,Douglas CB.Do statins prevent cardiovascular disease and fracture? JAMA,2000,283:3255-3258.
  • 2Bengtsson AK,Ryan EJ.Immune function of the decoy recepter osteoprotegerin.Crit Rev Immunol,2002,22:201-205.
  • 3Gravallese EM,Manning C,Tsay A,et al.Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum,2000,43:250-258.
  • 4Zauli G,Rimondi E,Nicolin V,et al.TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.Blood,2004,104:2044-2050
  • 5Hofbauer LC,Khosla S,Dunstan CR,et al.The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.J Bone Miner Res,2000,15:2-12.
  • 6Abdallah BM,Stilgren LS,Nissen N,et al.Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures.Calcif Tissue Int,2005,76:90-97.
  • 7Tsangari H,Findlay DM,Kuliwaba JS,et al.Increased expression of IL-6and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.Bone,2004,35:334-342.
  • 8Coetzee M,Kruger MC.Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio:a new approach to osteoporosis treatment? South Med J,2004,97:506-511.
  • 9Fahrleitner-Pammer A,Dobnig H,Piswanger-Soelkner C,et al.Osteoprotegerin serum levels in women:correlation with age,bone mass,bone turnover and fracture status.Wien Klin Wochenschr,2003,115:291-297.
  • 10Jorgensen HL,Kusk P,Madsen B,et al.Serum osteoprotegerin (OPG)and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios.J Bone Miner Metab,2004,22:132-138.

同被引文献151

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部